Prof. Carlos Simon, Co-Chairman at the upcoming 3rd Biomarker Meeting

Palacio de Congresos Valencia

Professor Carlos Simon will be Co-Chairman in the upcoming 3rd Biomarker Meeting in Personalized Reproductive Medicine which will take place next April 7th – 9th in Valencia, Spain.   He will also take part in the ENDOMETRIAL RECEPTIVITY ARRAY workshop, alongside reproductive genetic experts from IGENOMIX, company where he is Chief Scientific Officer.   ENDOMETRIAL RECEPTIVITY ARRAY: Prof. Carlos […]

Dr. Carlos Simon welcomes at IGENOMIX British TV channel, BBC

Dr. Carlos Simón, Chief Scientific Officer at IGENOMIX, had the great pleasure to welcome British TV channel BBC, for an interview alongside his team which will feature in an upcoming IVF documentary for BBC One. The One Show host, Alex Jones, shared on Twitter and Instagram her experience in the filming with Dr. Carlos Simon.   “Twitter”   […]

Prof. Carlos Simon takes part in the Upper Egypt Assisted Reproduction Symposium

  Prof. Carlos Simon will take part in the Upper Egypt Assisted Reproduction Symposium located at the Marriott Zamalek Hotel in Cairo, Egypt, from 4th to 5th February 2016.   Don’t miss the chance to listen to: Dr. Carlos Simón Dr. Carmen Rubio Embryology and Genetics Workshop Workshop 2 “New Technologies that Improve Success Rates and […]

Igenomix’s Scientific Director participates in Fertility & Sterility’s Journal Club Live

Igenomix Team

Carlos Simon MD, PhD, Scientific Director of Igenomix, and Product Development Manager Antonio Diez, PhD, took part in Fertility & Sterility’s November 2015 Journal Club Live where they discussed Igenomix’s study published in Fertility & Sterility as a SEMINAL CONTRIBUTION in the September 2015 issue “Mitochondrial DNA content as a viability score in human euploid embryos: Less is better1 […]

First 30 hours, key to knowing whether a human embryo will be chromosomally normal

Prof. Carlos Simon, Scientific Director at Igenomix, is one of the researchers taking part in this study. Scientists from Igenomix, University of Valencia, Stanford University and Oregon Health & Science University (OSHU) have discovered that it is possible to predict if a human embryo is going to be chromosomally normal or abnormal within the first […]

Gene therapy: The solution to avoid or correct mitochondrial diseases

Carlos Simon & Werner Arber

As part of the meetings of Excellence VLC/Campus, organized by the Rey Jaime I Awards Foundation, Igenomix hosted an institutional meeting between Dr. Werner Arber, Nobel Laureate in Medicine 1978 and Prof. Carlos Simon, scientific director of Igenomix and Rey Jaime I award winner in 2011 in the category of Medical Research. Both experts also discussed the systems […]

First 30 hours, key to knowing whether a human embryo will be chromosomally normal

Embryo

Prof. Carlos Simon, Scientific Director at Igenomix, is one of the researchers taking part in this study. Scientists from Igenomix, University of Valencia, Stanford University and Oregon Health & Science University (OSHU) have discovered that it is possible to predict if a human embryo is going to be chromosomally normal or abnormal within the first […]

MitoScore: Mitochondrial biomarker developed by Igenomix will increase implantation rate of in vitro fertilization

One of the great challenges of in vitro fertilization techniques is to be able to guarantee the viability of the transferred embryos to be implanted into the maternal uterus and be able to give birth to a healthy baby. Taking into account that the mitochondria are responsible for providing most of the energy necessary for […]